Growing community of inventors

Philadelphia, PA, United States of America

Valder R Arruda

Average Co-Inventor Count = 2.63

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Valder R ArrudaRodney M Camire (7 patents)Valder R ArrudaNicholas Iacobelli (3 patents)Valder R ArrudaBenjamin Samelson-Jones (2 patents)Valder R ArrudaKatherine A High (1 patent)Valder R ArrudaRoland W Herzog (1 patent)Valder R ArrudaPaul A Fields (1 patent)Valder R ArrudaLacramioara Ivanciu (1 patent)Valder R ArrudaGeerte Van Sluis (0 patent)Valder R ArrudaChristoffel Arnoldus Spek (0 patent)Valder R ArrudaValder R Arruda (9 patents)Rodney M CamireRodney M Camire (18 patents)Nicholas IacobelliNicholas Iacobelli (3 patents)Benjamin Samelson-JonesBenjamin Samelson-Jones (2 patents)Katherine A HighKatherine A High (28 patents)Roland W HerzogRoland W Herzog (3 patents)Paul A FieldsPaul A Fields (1 patent)Lacramioara IvanciuLacramioara Ivanciu (1 patent)Geerte Van SluisGeerte Van Sluis (0 patent)Christoffel Arnoldus SpekChristoffel Arnoldus Spek (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. The Children's Hospital of Philadelphia (9 from 281 patents)

2. Academisch Ziekenhuis Bij De Universiteit Van Amsterdam (5 patents)


9 patents:

1. 12252528 - Compositions and methods for modulating Factor VIII function

2. 11708570 - Compositions and methods for modulating Factor IX function

3. 10676731 - Compositions and methods for modulating factor IX function

4. 10442850 - Compositions and methods for enhancing coagulation factor VIII function

5. 9670267 - Compositions and methods for enhancing coagulation factor VIII function

6. 8816054 - Compositions and methods for enhancing coagulation Factor VIII function

7. 8470557 - Isolated nucleic acids encoding activated factor V and methods for production thereof

8. 8236764 - Methods for treating a hemostasis related disorder using activated forms of Factor V

9. 8063022 - Methods for preventing formation of inhibitory antibodies in the setting of gene therapy

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…